Abluminus DES+

Sirolimus Eluting Coronary Stent System

Technical Specification

Drug / Exipient
Drug	Sirolimus
Drug Dose	0.7 μg/mm2
Drug Carrier	Customized biodegradable polymer matrix

Stent
Stent Material	L605 Cobalt Chromium Alloy
Strut Thickness	73 µm
Strut Width	80 µm (hinge) - 120 µm (strut)

Delivery System
Delivery System	RX/Monorail
Nominal Pressure	8 Bar
Rated Burst Pressure	14 Bar*
Guidewire Compatibility (max)	0.014"
Guiding Catheter Compatibility	SF
Crossing Profile**	0.038"
Tip Entry Profile	0.016"

*The above diagram is just an illustration of the product.
Disclaimer: The law restricts these devices to sale by or on the order of a physician. Indications, contradictions, warnings can be found in the product labelling/ IFU supplied with each device. For restricted use only in countries where product is registered with applicable health authorities.

ENVISOLUTION TECHNOLOGY

1.ABLUMINAL COATING
Facilitates mono directional drug release and less systemic expose of drug leading to faster re-endothelialisation.

2.FUSION COATING
Coating on the stent and expose parts of the balloon facilitate homogeneous drug delivery which addresses diffused proliferative disease and focal restenosis.

3.EDGE COATING
Additional 0.5mm coating beyond the proximal and distal edge of the stent addresses the edge restenosis.

4.BIODEGRADABLE FILM
The formation of hypothetical circular film with biodegradable polymer due to elasticity of polymer facilitate maximum surface area for drug delivery in blood wet condition.

More About ABLUMINUS DES+

DIABETES MELLITUS

Patients with DM are more affected by coronary artery disease and when treated by PCI with stent implantation they remain at higher risk of in-stent restenosis and adverse cardiovascular events.
The etiology of this failure is likely to be multifactorial such as diffuse disease progression, small vessel and endothelial dysfunction.
The presence of DM (particularly insulin-treated DM) has been a consistent, independent predictor of in-stent restenosis.

STENT COMPARISON*

* GG Stefanini. M Taniwaki, S Windecker, Coronary stents: novel development, Heart doi:10.1136/heartjnl-2012-303522;
I Meredith, Scientific symposium, CT 2013; M Rothman, presentation TCT 2014

ABLUMINUS DES+